Injective falls as MACD and ADX signal persistent selling; $2.88 marks key near-term support

Traders Union
All News
Crypto News
Injective falls 6.77% this week

Highlights

INJ trades at $2.98, below its MA-20 ($3.82), MA-50 ($4.50), and MA-200 ($8.76), confirming short-, medium-, and long-term bearish trends.
Momentum indicators including MACD, ADX, and Bull/Bear Power all signal strong seller dominance, with RSI at 28.66 showing oversold conditions yet limited buyer interest.
Immediate resistance stands at the Ichimoku Kijun of $4.08, with support at $2.90 and a five-day trading range projected between $2.88 and $3.08.

Deeply oversold signals and weak momentum reinforce weekly downside

All weekly technical indicators reinforce a bearish view for INJ. The price remains below major moving averages and faces dynamic resistance at the Ichimoku Kijun ($4.08), while immediate support lingers around $2.90. Momentum is weak with both the MACD and ADX signaling persistent selling; RSI sits deeply oversold at 28.66, joined by the Stochastic RSI and CCI near oversold levels. Bear Power remains negative and the Awesome Oscillator is neutral, confirming the lack of meaningful bullish signals.

Sideways trading likely as downside risks dominate next week

INJ is likely to move within a tight consolidation range over the next week, expected between $2.88 and $3.08. The probability of upward movement remains low, with all major weekly indicators pointing toward sustained seller control. Near-term recovery would require a clear break above $3.10 and particularly $4.08, but risk of further downside persists if $2.88 support fails. The baseline scenario sees INJ trading sideways, with downside pressure dominating unless a positive catalyst emerges.

Viktoras Karapetjanc, expert at Traders Union, sees INJ in a phase of pronounced bearish sentiment this week, but he remains attentive to emerging opportunities. The ongoing downside pressure is clear from price action and broad technical weakness, yet oversold readings are beginning to create the conditions for an eventual rebound. Karapetjanc believes that as long as INJ holds above the $2.88 support zone, buyers have a potential setup for tactical accumulation, especially if sentiment improves. A confirmed break above $3.10 would be the first step toward recovery. "Despite the prevailing bearish momentum, I view this consolidation as a window for forward-looking investors to position for the next bullish cycle if key support holds."

Previously it was reported that Injective Protocol (INJ) is trading below key moving averages, with persistent selling pressure and all major momentum indicators—MACD, ADX, RSI, Stoch RSI, and CCI—signaling a deep oversold condition. Despite a notable intraday gain, price action remains capped by significant resistance at the Ichimoku Kijun, and ongoing bearish sentiment suggests downside risks persist.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.